140 related articles for article (PubMed ID: 23736690)
1. Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?
Ibeawuchi C; Schmidt H; Voss R; Titze U; Abbas M; Neumann J; Eltze E; Hoogland AM; Jenster G; Brandt B; Semjonow A
Int J Mol Sci; 2013 Jun; 14(6):11816-29. PubMed ID: 23736690
[TBL] [Abstract][Full Text] [Related]
2. High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer.
Boyd LK; Mao X; Xue L; Lin D; Chaplin T; Kudahetti SC; Stankiewicz E; Yu Y; Beltran L; Shaw G; Hines J; Oliver RT; Berney DM; Young BD; Lu YJ
Genes Chromosomes Cancer; 2012 Jun; 51(6):579-89. PubMed ID: 22334418
[TBL] [Abstract][Full Text] [Related]
3. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
Løvf M; Zhao S; Axcrona U; Johannessen B; Bakken AC; Carm KT; Hoff AM; Myklebost O; Meza-Zepeda LA; Lie AK; Axcrona K; Lothe RA; Skotheim RI
Eur Urol; 2019 Mar; 75(3):498-505. PubMed ID: 30181068
[TBL] [Abstract][Full Text] [Related]
4. Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer.
Kristiansen A; Bergström R; Delahunt B; Samaratunga H; Guðjónsdóttir J; Grönberg H; Egevad L; Lindberg J
Prostate; 2019 Jun; 79(8):920-928. PubMed ID: 30908670
[TBL] [Abstract][Full Text] [Related]
5. Spatial genomic heterogeneity within localized, multifocal prostate cancer.
Boutros PC; Fraser M; Harding NJ; de Borja R; Trudel D; Lalonde E; Meng A; Hennings-Yeomans PH; McPherson A; Sabelnykova VY; Zia A; Fox NS; Livingstone J; Shiah YJ; Wang J; Beck TA; Have CL; Chong T; Sam M; Johns J; Timms L; Buchner N; Wong A; Watson JD; Simmons TT; P'ng C; Zafarana G; Nguyen F; Luo X; Chu KC; Prokopec SD; Sykes J; Dal Pra A; Berlin A; Brown A; Chan-Seng-Yue MA; Yousif F; Denroche RE; Chong LC; Chen GM; Jung E; Fung C; Starmans MH; Chen H; Govind SK; Hawley J; D'Costa A; Pintilie M; Waggott D; Hach F; Lambin P; Muthuswamy LB; Cooper C; Eeles R; Neal D; Tetu B; Sahinalp C; Stein LD; Fleshner N; Shah SP; Collins CC; Hudson TJ; McPherson JD; van der Kwast T; Bristow RG
Nat Genet; 2015 Jul; 47(7):736-45. PubMed ID: 26005866
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study of germline copy number variations reveals an association with prostate cancer aggressiveness.
Brezina S; Feigl M; Gumpenberger T; Staudinger R; Baierl A; Gsur A
Mutagenesis; 2020 Jul; 35(3):283-290. PubMed ID: 32255470
[TBL] [Abstract][Full Text] [Related]
7. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer.
Kim TM; Jung SH; Baek IP; Lee SH; Choi YJ; Lee JY; Chung YJ; Lee SH
J Pathol; 2014 Aug; 233(4):425-35. PubMed ID: 24870262
[TBL] [Abstract][Full Text] [Related]
8. Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy.
Karavitakis M; Ahmed HU; Abel PD; Hazell S; Winkler MH
Ther Adv Urol; 2012 Aug; 4(4):155-60. PubMed ID: 22852025
[TBL] [Abstract][Full Text] [Related]
9. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
10. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen.
Djavan B; Susani M; Bursa B; Basharkhah A; Simak R; Marberger M
Tech Urol; 1999 Sep; 5(3):139-42. PubMed ID: 10527256
[TBL] [Abstract][Full Text] [Related]
11. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
Liu W; Laitinen S; Khan S; Vihinen M; Kowalski J; Yu G; Chen L; Ewing CM; Eisenberger MA; Carducci MA; Nelson WG; Yegnasubramanian S; Luo J; Wang Y; Xu J; Isaacs WB; Visakorpi T; Bova GS
Nat Med; 2009 May; 15(5):559-65. PubMed ID: 19363497
[TBL] [Abstract][Full Text] [Related]
12. Tumor focality is not associated with biochemical outcome after radical prostatectomy.
Iremashvili V; Pelaez L; Manoharan M; Acosta K; Rosenberg DL; Soloway MS
Prostate; 2012 May; 72(7):762-8. PubMed ID: 21882214
[TBL] [Abstract][Full Text] [Related]
13. Computer-assisted three-dimensional analysis of multifocal/multicentric prostate cancer.
Fujii T; Ishida E; Shimada K; Hirao K; Tanaka N; Fujimoto K; Konishi N
Cancer Invest; 2014 Aug; 32(7):303-10. PubMed ID: 24827595
[TBL] [Abstract][Full Text] [Related]
14. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS
PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534
[TBL] [Abstract][Full Text] [Related]
15. Genomic and phenotypic heterogeneity in prostate cancer.
Haffner MC; Zwart W; Roudier MP; True LD; Nelson WG; Epstein JI; De Marzo AM; Nelson PS; Yegnasubramanian S
Nat Rev Urol; 2021 Feb; 18(2):79-92. PubMed ID: 33328650
[TBL] [Abstract][Full Text] [Related]
16. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
17. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
Bostwick DG; Shan A; Qian J; Darson M; Maihle NJ; Jenkins RB; Cheng L
Cancer; 1998 Nov; 83(9):1995-2002. PubMed ID: 9806659
[TBL] [Abstract][Full Text] [Related]
18. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.
Brocks D; Assenov Y; Minner S; Bogatyrova O; Simon R; Koop C; Oakes C; Zucknick M; Lipka DB; Weischenfeldt J; Feuerbach L; Cowper-Sal Lari R; Lupien M; Brors B; Korbel J; Schlomm T; Tanay A; Sauter G; Gerhäuser C; Plass C;
Cell Rep; 2014 Aug; 8(3):798-806. PubMed ID: 25066126
[TBL] [Abstract][Full Text] [Related]
19. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
20. Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.
Ibeawuchi C; Schmidt H; Voss R; Titze U; Abbas M; Neumann J; Eltze E; Hoogland AM; Jenster G; Brandt B; Semjonow A
Int J Mol Sci; 2015 Feb; 16(2):3856-69. PubMed ID: 25679447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
